Financial toxicity is a significant issue for individuals with blood cancer, encompassing factors beyond just drug costs, such as childcare, transportation, and lost income. Addressing this issue requires efforts at the clinic, system, and policy levels. Proactively screening for financial toxicity and implementing financial navigation are key actions clinicians can take at the individual level. Large hospital systems can leverage their power to address financial toxicity through initiatives like a financial toxicity tumor board. Addressing financial toxicity at a policy level is also important, although the future of policymaking in this area may be uncertain.
Source link
Mitigating financial toxicity ’better than any drug’ for people with cancer
